FIBROGEN INC — Director's Dealing 2024

Apr 24, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2024-04-22

Reporting Person: Adib Deyaa (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	60000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1.71	2034-03-10	Common Stock (300000)		Direct

Footnotes

F1: Represents restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 11, 2025, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.

F2: Twenty-five percent of the shares subject to the option will vest on March 11, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.